Borderline Personality Disorder (BPD)

Tovani does not treat this with ketamine

This page is here for honesty and completeness. Ketamine is not an appropriate treatment for Borderline Personality Disorder, and in some cases it is contraindicated. Below is what the condition is and the treatments that genuinely help — and where, if at all, ketamine has any narrow role (usually only for a separate co-occurring depression). If you’re in crisis, call or text 988.

The short version

●BPD is a disorder of pervasive instability in emotions, self-image, and relationships, with impulsivity and recurrent self-harm or suicidal behavior, beginning by early adulthood.
●It is genuinely treatable — and the core treatment is specialized psychotherapy (DBT, mentalization-based therapy, schema therapy, and others), not medication.
●Ketamine is not a treatment for BPD itself; the emotion dysregulation, identity, and relationship patterns at its core respond to skills-based and relational therapy, not to a drug.
●BPD also carries a high suicide risk, and recurrent suicidality is managed within that specialized therapy and safety planning — not as a ketamine indication.
●The one genuine, separate question is a co-occurring treatment-resistant major depression, which is common in BPD and can be treated cautiously with ketamine — but the BPD is treated with therapy.
●Tovani does not treat BPD itself; where a clearly diagnosed treatment-resistant depression co-occurs, that depression may be addressed alongside ongoing specialized BPD care.

Clinical definition

Borderline personality disorder is a pervasive pattern of instability in interpersonal relationships, self-image, and affect, with marked impulsivity, beginning by early adulthood and present across contexts. DSM-5 lists nine criteria (five required): frantic efforts to avoid abandonment; unstable, intense relationships; identity disturbance; impulsivity in at least two potentially self-damaging areas; recurrent suicidal behavior or self-harm; affective instability; chronic emptiness; inappropriate intense anger; and transient stress-related paranoia or dissociation. At its core are difficulties regulating intense emotions and maintaining a stable sense of self and relationships, frequently rooted in temperament plus invalidating or traumatic early environments. BPD carries a high rate of self-harm and a markedly elevated suicide risk. Critically, it is treatable, and the treatments that work are specialized psychotherapies — which is why BPD itself is not a ketamine indication, even though a co-occurring depression might be.

How it differs from related conditions

vs. Bipolar 2 depression

Bipolar mood shifts are sustained (days-weeks) and episodic; BPD's affective instability is rapid (hours), reactive to interpersonal triggers, and more constant.

vs. Complex PTSD

Substantial overlap (affect dysregulation, relationship difficulty, trauma roots); cPTSD centers on trauma sequelae, and many people meet criteria for both.

vs. Major depressive disorder

A common comorbidity; the chronic emptiness and reactivity of BPD differ from a discrete depressive episode, though the two frequently co-occur.

vs. Emotional dysregulation

Emotion dysregulation is the core feature of BPD but also a transdiagnostic symptom; BPD is the broader personality-level pattern.

First-line treatments

Dialectical behavior therapy (DBT)

The best-evidenced treatment — builds emotion regulation, distress tolerance, mindfulness, and interpersonal skills, and reduces self-harm and suicidality.

Other structured psychotherapies

Mentalization-based therapy, schema therapy, and transference-focused therapy also have evidence for BPD.

Medication (limited, adjunctive)

No medication treats BPD itself; medications target specific co-occurring symptoms (depression, anxiety) and are used cautiously to avoid polypharmacy.

Safety planning and crisis support

Given high suicide and self-harm risk, structured safety planning and crisis resources are integral.

When standard treatments fail

When progress stalls, the steps are to ensure access to an adequate, genuinely BPD-specific therapy (DBT and the other evidence-based models are often unavailable or under-dosed), address co-occurring depression, PTSD, and substance use, and maintain safety planning. Ketamine is not a treatment for BPD; the one separate question it raises is a co-occurring treatment-resistant depression, treated cautiously alongside ongoing specialized therapy.

Where ketamine fits

Ketamine is not a treatment for borderline personality disorder. The disorder's core — pervasive emotion dysregulation, identity instability, and relationship difficulties — responds to specialized, skills-based and relational psychotherapy (DBT and others), not to a medication, and certainly not to a single drug effect. BPD also carries a high suicide risk, which is managed within that therapy and safety planning rather than treated as a ketamine indication. Where the honest nuance lies is comorbidity: treatment-resistant major depression is common in BPD, and that depression can in principle be treated with ketamine — cautiously, alongside ongoing BPD-specific therapy, and with the understanding that it addresses the depression, not the personality disorder. So the BPD itself is not an indication; a co-occurring treatment-resistant depression is a separate, carefully managed question.

Where this fits with Tovani

Tovani does not treat borderline personality disorder itself — DBT and other specialized psychotherapies are the genuine, effective treatments, and we'd direct you toward them. Eligibility screening captures the clinical picture. Where a clearly diagnosed treatment-resistant major depression co-occurs (common in BPD), that depression may be treated with ketamine cautiously and alongside ongoing BPD-specific therapy and safety planning — but the BPD is treated with therapy. If you're having thoughts of self-harm, call or text 988.

Check eligibility Find treatment options The science behind ketamine

Frequently asked

Can ketamine treat borderline personality disorder?

No — BPD itself isn't a ketamine indication. Its core (emotion dysregulation, identity and relationship instability) responds to specialized therapy like DBT, not to a drug. The one separate question is a co-occurring treatment-resistant depression, which is common in BPD and can be treated cautiously with ketamine alongside ongoing therapy — but that treats the depression, not the BPD.

What actually treats BPD?

Specialized psychotherapy — dialectical behavior therapy (DBT) has the strongest evidence, with mentalization-based, schema, and transference-focused therapies also effective. Medication doesn't treat BPD itself; it targets specific co-occurring symptoms. BPD is genuinely treatable, and many people improve substantially.

I have BPD and severe depression — is ketamine an option for the depression?

Possibly, and cautiously. Treatment-resistant depression is common in BPD, and ketamine can treat that depression — but alongside ongoing BPD-specific therapy and safety planning, and with the understanding it addresses the depression, not the personality disorder. The therapy remains central.

Does ketamine help with the emotional intensity of BPD?

Not as a treatment for it. The intense, rapidly shifting emotions of BPD are addressed durably through DBT and related skills-based therapies. If a treatment-resistant depression is layered on top, lifting it may ease overall distress — but the regulation work is what changes the BPD pattern.

References

Storebø OJ et al. 2020, Cochrane Database of Systematic Reviews — Systematic review of psychological therapies for borderline personality disorder, with DBT among the best-supported — establishing therapy, not medication, as core treatment. (PMID 32368793)
Murrough JW et al. 2013, American Journal of Psychiatry — Ketamine RCT in treatment-resistant depression, relevant only to a co-occurring depression alongside specialized BPD therapy. (PMID 23982301)

Last reviewed by Dr. Ben Soffer, DO on May 31, 2026. This page is educational and not a substitute for clinical evaluation. A physician determines whether ketamine therapy is appropriate for your specific situation.